The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products

J Immunol. 2002 Apr 1;168(7):3464-9. doi: 10.4049/jimmunol.168.7.3464.

Abstract

Human CMV encodes four unique short region proteins (US), US2, US3, US6, and US11, each independently sufficient for causing the down-regulation of MHC class I molecules on the cell surface. This down-regulation allows infected cells to evade recognition by cytotoxic T cells but leaves them susceptible to NK cells, which lyse cells that lack class I molecules. Another human CMV-encoded protein, unique long region protein 18 (UL18), is an MHC class I homolog that might provide a mechanism for inhibiting the NK cell response. The sequence similarities between MHC class I molecules and UL18 along with the ability of UL18 to form trimeric complexes with beta(2)-microglobulin and peptides led to the hypothesis that if the US and UL18 gene products coexist temporally during infection, the US proteins might down-regulate UL18 molecules, similar to their action on MHC class I molecules. We show here that temporal expression of US and UL18 genes partially overlaps during infection. However, unlike MHC class I molecules, the MHC class I homolog, UL18, is fully resistant to the down-regulation associated with the US2, US3, US6, and US11 gene products. The specific effect of US proteins on MHC class I molecules, but not on UL18, represents another example of how viral proteins have evolved to evade immune surveillance, avoiding fratricide by specifically targeting host proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / physiology
  • Capsid / antagonists & inhibitors
  • Capsid / biosynthesis*
  • Capsid / genetics
  • Capsid / metabolism
  • Capsid Proteins*
  • Cytomegalovirus / immunology*
  • Down-Regulation* / genetics
  • Down-Regulation* / immunology
  • Glycoproteins
  • HeLa Cells
  • Histocompatibility Antigens Class I / biosynthesis*
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Immediate-Early Proteins / biosynthesis
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / physiology*
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / biosynthesis
  • RNA-Binding Proteins / biosynthesis
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / physiology*
  • Sequence Homology, Amino Acid
  • Tumor Cells, Cultured
  • Viral Envelope Proteins / biosynthesis
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / physiology*
  • Viral Proteins / biosynthesis
  • Viral Proteins / genetics
  • Viral Proteins / physiology*

Substances

  • ATP-Binding Cassette Transporters
  • Capsid Proteins
  • Glycoproteins
  • Histocompatibility Antigens Class I
  • Immediate-Early Proteins
  • Membrane Proteins
  • RNA-Binding Proteins
  • US11 protein, herpesvirus
  • US2 protein, Varicellovirus
  • US3 protein, cytomegalovirus
  • US6 protein, Human cytomegalovirus
  • VP23 protein, Human herpesvirus 1
  • Viral Envelope Proteins
  • Viral Proteins